» Articles » PMID: 25729483

Post-transplantation Hepatocellular Carcinoma Recurrence: Patterns and Relation Between Vascularity and Differentiation Degree

Overview
Journal World J Hepatol
Specialty Gastroenterology
Date 2015 Mar 3
PMID 25729483
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate the relationship between hepatocellular carcinoma (HCC) vascularity and grade; to describe patterns and vascular/histopathological variations of post-transplantation recurrence.

Methods: This retrospective study included 165 patients (143 men, 22 women; median age 56.8 years, range 28-70.4 years) transplanted for HCC who had a follow-up period longer than 2 mo. Pre-transplantation dynamic computed tomography or magnetic resonance examinations were retrospectively reviewed, classifying HCC imaging enhancement pattern into hypervascular and hypovascular based on presence of wash-in during arterial phase. All pathologic reports of the explanted livers were reviewed, collecting data about HCC differentiation degree. The association between imaging vascular pattern and pathological grade was estimated using the Fisher exact test. All follow-up clinical and imaging data were reviewed for evidence of recurrence. Recurrence rate was calculated and imaging features of recurrent tumor were collected, classifying early and late recurrences based on timing (< or ≥ 2 years after transplantation) and intrahepatic, extrahepatic and both intrahepatic and extrahepatic recurrences based on location. All intrahepatic recurrences were classified as hypervascular or hypovascular and the differentiation degree was collected where available. The presence of variations in imaging enhancement pattern and pathological grade between the primary tumor and the intrahepatic recurrence was evaluated and the association between imaging and histopatholgical variations was estimated by using the χ(2) test.

Results: Of the 163 patients with imaging evidence of viable tumor, 156 (95.7%) had hypervascular and 7 (4.3%) hypovascular HCC. Among the 125 patients with evidence of viable tumor in the explanted liver, 19 (15.2%) had grade 1, 56 (44.8%) grade 2, 40 (32%) grade 3 and 4 (3.2%) grade 4 HCC, while the differentiation degree was not assessable for 6 patients (4.8%). A significant association was found between imaging vascularity and pathological grade (P = 0.035). Post-transplantation recurrence rate was 14.55% (24/165). All recurrences occurred in patients who had a hypervascular primary tumor. Three patients (12.5%) experienced late recurrence; the location of the first recurrence was extrahepatic in 14 patients (58.3%), intrahepatic in 7 patients (29.2%) and both intrahepatic and extrahepatic in 3 patients (12.5%). Two patients had a variation in imaging characteristics between the primary HCC (hypervascular) and the intrahepatic recurrent HCC (hypovascular), while 1 patient had a variation of histopathological characteristics (from moderate to poor differentiation), however no association was found between imaging and histopathological variations.

Conclusion: A correlation was found between HCC grade and vascularity; some degree of variability may exist between the primary and the recurrence imaging/histopathological characteristics, apparently not correlated.

Citing Articles

Imaging of hepatocellular carcinoma recurrence after liver transplantation.

Mamone G, Caruso S, Milazzo M, Porrello G, Di Piazza A, Gentile G Insights Imaging. 2023; 14(1):84.

PMID: 37184688 PMC: 10185729. DOI: 10.1186/s13244-023-01425-6.


Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study.

Yan W, Li C, Yao L, Qiu H, Wang M, Xu X Hepatobiliary Surg Nutr. 2023; 12(2):155-168.

PMID: 37124678 PMC: 10129892. DOI: 10.21037/hbsn-21-288.


CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling.

Chen Z, Yuan T, Yan F, Ye S, Xie Q, Zhang B BMC Cancer. 2022; 22(1):425.

PMID: 35440025 PMC: 9020089. DOI: 10.1186/s12885-022-09520-5.


Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Wang M, Li C, Liang L, Xing H, Sun L, Quan B Oncologist. 2020; 25(10):e1541-e1551.

PMID: 32472951 PMC: 7543359. DOI: 10.1634/theoncologist.2019-0944.


Reduction of FoxP3 Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma.

Zhou L, Pan L, Zheng Y, Zhang X, Liu Z, Meng X Ann Transl Med. 2020; 8(7):472.

PMID: 32395516 PMC: 7210174. DOI: 10.21037/atm.2020.03.129.


References
1.
Ayuso C, Rimola J, Garcia-Criado A . Imaging of HCC. Abdom Imaging. 2011; 37(2):215-30. DOI: 10.1007/s00261-011-9794-x. View

2.
Kim Y, Lim H, Rhim H, Lee W, Joh J, Park C . Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features. AJR Am J Roentgenol. 2007; 189(2):352-8. DOI: 10.2214/AJR.07.2088. View

3.
Okamoto D, Yoshimitsu K, Nishie A, Tajima T, Asayama Y, Ishigami K . Enhancement pattern analysis of hypervascular hepatocellular carcinoma on dynamic MR imaging with histopathological correlation: validity of portal phase imaging for predicting tumor grade. Eur J Radiol. 2011; 81(6):1116-21. DOI: 10.1016/j.ejrad.2011.02.056. View

4.
Chung G, Lee J, Yoon J, Myung S, Lee K, Jang J . Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma. Abdom Imaging. 2011; 37(3):439-46. DOI: 10.1007/s00261-011-9756-3. View

5.
Yoon S, Lee J, So Y, Hong S, Kim S, Han J . Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol. 2009; 193(6):W482-9. DOI: 10.2214/AJR.08.1818. View